Related Experiment Video

Updated: Aug 10, 2026

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
10:44

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

Extrahepatic cytochrome P450: role in in situ toxicity and cell-specific hormone sensitivity

M Warner1, H Hellmold, M Magnusson

  • 1Department of Bioscience, NOVUM, Karolinska Institute, Huddinge, Sweden.

Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement
|January 27, 1998
PubMed

Insights

Cytochrome P450 enzymes activate most procarcinogens. Their activity, influenced by environment and diet, determines cellular carcinogen metabolism and hormone sensitivity.

Area of Science:

  • Biochemistry
  • Toxicology
  • Molecular Biology

Background:

  • Cytochrome P450 (P450) enzymes are crucial for metabolizing various compounds.
  • These enzymes activate procarcinogens, such as heterocyclic amines and polycyclic aromatic hydrocarbons, into ultimate carcinogens.
  • The P450 profile within a cell reflects its capacity to generate reactive metabolites.

Purpose of the Study:

  • To highlight the role of Cytochrome P450 enzymes in procarcinogen activation.
  • To discuss how environmental factors and cellular P450 profiles influence carcinogen metabolism.
  • To explore the impact of P450s on hormone sensitivity and their tissue-specific regulation.

Main Methods:

  • Review of existing literature on Cytochrome P450 function.
  • Analysis of P450 isoform regulation by environmental factors (ethanol, diet, inducers).
  • Examination of P450 substrate specificities and interactions with dietary components.

Main Results:

  • P450 enzymes are central to the activation of numerous procarcinogens found in food, pesticides, and environmental pollutants.
  • Cellular P450 profiles dictate the potential for reactive metabolite formation.
  • Environmental factors, dietary components, and specific P450 isoforms differentially regulate metabolic activation and inactivation pathways.

Conclusions:

  • Cytochrome P450 enzymes play a pivotal role in carcinogen activation and hormone metabolism.
  • Tissue-specific P450 isoform expression, influenced by age and hormones, suggests localized carcinogen activation and hormone inactivation, particularly noted in breast tissue.
  • Further research is needed to fully identify P450 isoforms in tissues like the brain and endometrium.

More Related Videos

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling09:33

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Published on: March 20, 2018

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure08:25

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Factors Affecting Drug Biotransformation: Biological01:19

Factors Affecting Drug Biotransformation: Biological

Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...